ストックスクリーナーアプリを入手
5.95
1.71%
0.10
アフターアワーズ：
6.00
0.05
+0.84%
前日終値:
$5.85
開ける：
$5.78
24時間の取引高:
1.04M
Relative Volume:
0.55
時価総額：
$966.65M
収益：
$25.55M
当期純損益:
$-341.97M
株価収益率:
-2.2119
EPS:
-2.69
ネットキャッシュフロー:
$-304.44M
1週間 パフォーマンス:
+0.85%
1か月 パフォーマンス:
-8.88%
6か月 パフォーマンス:
-15.48%
1年 パフォーマンス:
-20.88%
1日の値動き範囲:
$5.66
$6.00
1週間の範囲:
$5.60
$6.09
52週間の値動き範囲:
$5.60
$12.14
Relay Therapeutics Inc Stock (RLAY) Company Profile
Relay Therapeutics Inc Stock (RLAY) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2023-04-20 | アップグレード | Jefferies | Underperform → Hold |
| 2023-04-19 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2023-04-13 | 開始されました | Raymond James | Outperform |
| 2023-02-03 | 開始されました | Oppenheimer | Outperform |
| 2022-09-30 | 開始されました | Barclays | Equal Weight |
| 2022-09-02 | 開始されました | Stifel | Buy |
| 2022-06-06 | 開始されました | Jefferies | Underperform |
| 2022-02-01 | 開始されました | Berenberg | Buy |
| 2021-07-21 | 開始されました | BofA Securities | Buy |
| 2020-12-15 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-12-08 | 開始されました | JMP Securities | Mkt Outperform |
| 2020-11-05 | 開始されました | H.C. Wainwright | Buy |
| 2020-08-10 | 開始されました | Cowen | Outperform |
| 2020-08-10 | 開始されました | Goldman | Buy |
| 2020-08-10 | 開始されました | Guggenheim | Buy |
| 2020-08-10 | 開始されました | JP Morgan | Neutral |
すべてを表示
Relay Therapeutics Inc (RLAY) 最新ニュース
Where are the Opportunities in (RLAY) - Stock Traders Daily
Layoff Tracker: Compass Pathways to Lay Off 30% of Employees - BioSpace
Relay Therapeutics (RLAY) to Release Earnings on Wednesday - MarketBeat
Relay Therapeutics stock hits 52-week low at $5.7 amid market shifts - Investing.com India
Relay Therapeutics stock hits 52-week low at $5.7 amid market shifts By Investing.com - Investing.com South Africa
Relay Therapeutics to Announce Third Quarter 2024 Financial Results and Corporate Highlights on November 6, 2024 - The Manila Times
Relay Therapeutics to Announce Third Quarter 2024 Financial Results and Corporate Highlights on November 6, - EIN News
Intrahepatic Cholangiocarcinoma Pipeline Update 2024: FDA Approvals, Therapeutic Advancements, and Key Companies involved by DelveInsight | Xencor, Relay Therapeutics, Kinnate Biopharma, Forma Therapy - Barchart
Institutional owners may consider drastic measures as Relay Therapeutics, Inc.'s (NASDAQ:RLAY) recent US$67m drop adds to long-term losses - Yahoo Finance
Relay Therapeutics, Inc. (NASDAQ:RLAY) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Several Relay Therapeutics Insiders Sell Shares Sending Potential Negative Signal - Simply Wall St
Relay Therapeutics' SWOT analysis: oncology innovator's stock faces pivotal phase - Investing.com Canada
Relay Therapeutics' SWOT analysis: oncology innovator's stock faces pivotal phase By Investing.com - Investing.com South Africa
Financial Snapshot: Analyzing Relay Therapeutics Inc (RLAY)’s Key Ratio Metrics - The Dwinnex
Relay Therapeutics, Inc. (NASDAQ:RLAY) Short Interest Update - MarketBeat
How did Relay Therapeutics Inc (RLAY) fare last session? - US Post News
Relay Therapeutics (NASDAQ:RLAY) Receives Buy Rating from HC Wainwright - MarketBeat
Relay Therapeutics stock holds price target on FDA approval By Investing.com - Investing.com UK
Relay Therapeutics Inc (RLAY) receives a Buy rating from Jefferies - Knox Daily
(RLAY) Trading Report - Stock Traders Daily
Relay Therapeutics (NASDAQ:RLAY) Sees Unusually-High Trading VolumeStill a Buy? - MarketBeat
Relay Therapeutics Inc: Analyzing RLAY Stock Trends - The InvestChronicle
Relay Therapeutics Inc [NASDAQ: RLAY] Sees Increase in Stock Value - Knox Daily
Millennium Management LLC Purchases 921,271 Shares of Relay Therapeutics, Inc. (NASDAQ:RLAY) - MarketBeat
Relay Therapeutics (NASDAQ:RLAY) Shares Down 4%Here's Why - MarketBeat
Its Stock Has Paid Off Big Time For Relay Therapeutics Inc - SETE News
Thrivent Financial for Lutherans Purchases New Shares in Relay Therapeutics, Inc. (NASDAQ:RLAY) - MarketBeat
Relay Therapeutics Inc (RLAY) is a good investment, but the stock may be overvalued - US Post News
Ratio Analysis: Unpacking Relay Therapeutics Inc (RLAY)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
Relay Therapeutics Inc (RLAY) may enjoy gains as insiders got busy in the recent days - Knox Daily
Relay Therapeutics, Inc. (NASDAQ:RLAY) Shares Sold by Dimensional Fund Advisors LP - MarketBeat
Marshall Wace LLP Purchases New Stake in Relay Therapeutics, Inc. (NASDAQ:RLAY) - MarketBeat
Relay Therapeutics to Lay Off 10% of Workforce - BioSpace
Relay Therapeutics cuts 10% of staff after positive trial data - The Business Journals
insider Rahmer Peter sale 245 shares of Relay Therapeutics Inc [RLAY] - Knox Daily
Relay Therapeutics, Inc. (NASDAQ:RLAY) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Relay Therapeutics executive sells shares worth over $2,200 By Investing.com - Investing.com Australia
Stocks of Relay Therapeutics Inc (RLAY) are poised to climb above their peers - SETE News
RLAY’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - The InvestChronicle
Relay Therapeutics executive sells shares worth over $4,800 - Investing.com India
Biotech layoff tracker: 13 biotechs cut over 1,400 jobs - The Business Journals
Relay Therapeutics executive sells shares worth over $2,200 - Investing.com
Relay Therapeutics executive sells shares worth over $4,800 By Investing.com - Investing.com Australia
Relay Therapeutics Inc (RLAY) 財務データ
収益
当期純利益
現金流量
EPS
Relay Therapeutics Inc (RLAY) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Catinazzo Thomas | Chief Financial Officer |
Oct 28 '24 |
Sale |
6.06 |
6,802 |
41,220 |
306,391 |
| Catinazzo Thomas | Chief Financial Officer |
Oct 29 '24 |
Sale |
5.95 |
2,300 |
13,685 |
304,091 |
| Bergstrom Donald A | President, R&D |
Oct 28 '24 |
Sale |
6.06 |
2,688 |
16,289 |
520,745 |
| Adams Brian | Chief Legal Officer |
Oct 28 '24 |
Sale |
6.06 |
1,632 |
9,890 |
321,907 |
2.02%
0.47%
大文字化:
|
ボリューム (24 時間):